The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.

The programme aims to enhance access to targeted cancer therapies by identifying actionable genetic mutations in lung cancer patients ...

India has emerged as a growing player in the illicit fentanyl trade, a new US intelligence report says, a designation likely ...

Kotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare, supporting the pharma company's expansion ...

Kotak Alternate Asset Managers has invested Rs 1,050 crore in Tirupati Medicare, facilitating the pharma company's growth and ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

James Lawless, Ireland's Minister for Education, discusses educational collaborations with India, emphasizing strong ties and ...

Indian benchmark indices, Sensex and Nifty, ended in the green on Wednesday, extending their rebound for a third consecutive ...

Exhivision Media has announced the fourteenth edition of Pharmalabchem Expo – India’s premier exhibition dedicated to the pharmaceutical, lab, and related industries. The event will be held from May 8 ...

Pfizer had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So last year the company created a phone line ...

India’s No.1 News Magazine Making Sense of India. Check the list of all India Today magazine in digital format with edition, March 24, 2025.

Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells pills for between $1 and $5 per bottle in the US and tariffs "do not ...